A chemically modified oligonucleotide has been engineered to specifically target and interact with the nucleases associated with S. pneumoniae , enabling efficient detection of the bacteria through fluorescence and electrochemical biosensors.
No takes yet. Share an insight, caveat, or question.
Goikoetxea et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: